Literature DB >> 25819117

A galectin from shrimp Litopenaeus vannamei is involved in immune recognition and bacteria phagocytosis.

Fujun Hou1, Yongjie Liu1, Shulin He1, Xianzong Wang1, Aitao Mao2, Zhigang Liu2, Chengbo Sun2, Xiaolin Liu3.   

Abstract

Galectins are conserved family members with β-galactosides affinity that play multiple functions in embryogenesis, development and regulation of innate and adaptive immunity. However, little functional studies were reported in crustaceans. Here, a shrimp Litopenaeus vannamei galectin (LvGal) cDNA was identified with an open reading frame of 1017 bp, which encodes a putative protein of 338 amino acids. A carbohydrate recognition domain (CRD) and several amino acids residues involved in dimerization were found in LvGal. LvGal mRNA was mainly expressed in gills and hemocytes and upregulated post Vibrio anguillarum challenge. Recombinant LvGal (rLvGal) was expressed in Escherichia coli BL21 (DE3) and the purified rLvGal could strongly bind G(-) bacteria V. anguillarum and G(+) bacteria Micrococcus lysodeikticus. Besides, rLvGal exhibited strong activity to agglutinate V. anguillarum and weak activity to agglutinate M. lysodeikticus but no obvious antibacterial activity was found with selected bacteria. In addition, in vivo experiments showed rLvGal could promote phagocytosis of bacteria by hemocytes. Thus, through these collective data we predicted LvGal is involved in immune recognition and functions as a potential pattern recognition receptor.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bacteria; Galectin; Litopenaeus vannamei; Pattern recognition receptor

Mesh:

Substances:

Year:  2015        PMID: 25819117     DOI: 10.1016/j.fsi.2015.03.017

Source DB:  PubMed          Journal:  Fish Shellfish Immunol        ISSN: 1050-4648            Impact factor:   4.581


  1 in total

Review 1.  Hemocyte-Mediated Phagocytosis in Crustaceans.

Authors:  Shan Liu; Shu-Cheng Zheng; Yan-Lian Li; Jun Li; Hai-Peng Liu
Journal:  Front Immunol       Date:  2020-03-03       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.